Header cover image

New Zealand (NZX) Biotech Industry Analysis

UpdatedMay 19, 2024
DataAggregated Company Financials
Companies1
  • 7D8.9%
  • 3M14.0%
  • 1Y-78.5%
  • YTD-21.0%

Over the last 7 days, the Biotech industry has dropped 3.5%, driven by declines from every company within the industry. However, the industry is down 82% over the past year. As for the next few years, earnings are expected to grow by 39% per annum.

Industry Valuation and Performance

Has the New Zealand Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 19 May 2024NZ$79.5mNZ$25.5m-NZ$31,646,000.00n/a-2.5x3.1x
Tue, 16 Apr 2024NZ$69.0mNZ$25.5m-NZ$31,646,000.00n/a-2.2x2.7x
Thu, 14 Mar 2024NZ$73.0mNZ$25.5m-NZ$31,646,000.00n/a-2.3x2.9x
Sat, 10 Feb 2024NZ$78.7mNZ$25.5m-NZ$31,646,000.00n/a-2.5x3.1x
Mon, 08 Jan 2024NZ$89.2mNZ$25.5m-NZ$31,646,000.00n/a-2.8x3.5x
Wed, 06 Dec 2023NZ$79.5mNZ$25.5m-NZ$31,646,000.00n/a-2.5x3.1x
Fri, 03 Nov 2023NZ$83.5mNZ$21.0m-NZ$26,965,000.00n/a-3.1x4x
Sun, 01 Oct 2023NZ$98.5mNZ$21.0m-NZ$26,965,000.00n/a-3.7x4.7x
Tue, 29 Aug 2023NZ$78.6mNZ$21.0m-NZ$26,965,000.00n/a-2.9x3.7x
Thu, 27 Jul 2023NZ$154.0mNZ$21.0m-NZ$26,965,000.00n/a-5.7x7.3x
Sat, 24 Jun 2023NZ$58.3mNZ$21.0m-NZ$26,965,000.00n/a-2.2x2.8x
Mon, 22 May 2023NZ$368.7mNZ$16.5m-NZ$21,374,000.00n/a-17.3x22.4x
Wed, 19 Apr 2023NZ$372.8mNZ$16.5m-NZ$21,374,000.00n/a-17.4x22.6x
Fri, 17 Mar 2023NZ$364.7mNZ$16.5m-NZ$21,374,000.00n/a-17.1x22.1x
Sun, 12 Feb 2023NZ$380.9mNZ$16.5m-NZ$21,374,000.00n/a-17.8x23.1x
Tue, 10 Jan 2023NZ$397.1mNZ$16.5m-NZ$21,374,000.00n/a-18.6x24.1x
Thu, 08 Dec 2022NZ$368.6mNZ$16.5m-NZ$21,374,000.00n/a-17.2x22.4x
Sat, 05 Nov 2022NZ$344.3mNZ$13.1m-NZ$19,788,000.00n/a-17.4x26.2x
Mon, 03 Oct 2022NZ$405.1mNZ$13.1m-NZ$19,788,000.00n/a-20.5x30.8x
Wed, 31 Aug 2022NZ$356.5mNZ$13.1m-NZ$19,788,000.00n/a-18x27.1x
Fri, 29 Jul 2022NZ$631.9mNZ$13.1m-NZ$19,788,000.00n/a-31.9x48.1x
Sun, 26 Jun 2022NZ$550.9mNZ$13.1m-NZ$19,788,000.00n/a-27.8x41.9x
Tue, 24 May 2022NZ$656.2mNZ$11.5m-NZ$16,115,000.00n/a-40.7x57x
Thu, 21 Apr 2022NZ$745.3mNZ$11.5m-NZ$16,115,000.00n/a-46.2x64.7x
Sat, 19 Mar 2022NZ$753.4mNZ$11.5m-NZ$16,115,000.00n/a-46.8x65.4x
Mon, 14 Feb 2022NZ$850.5mNZ$11.5m-NZ$16,115,000.00n/a-52.8x73.8x
Wed, 12 Jan 2022NZ$1.1bNZ$11.5m-NZ$16,115,000.00n/a-66.3x92.8x
Fri, 10 Dec 2021NZ$1.1bNZ$11.5m-NZ$16,115,000.00n/a-66.3x92.8x
Sun, 07 Nov 2021NZ$1.2bNZ$9.0m-NZ$14,223,000.00n/a-82.5x130.7x
Tue, 05 Oct 2021NZ$1.2bNZ$9.0m-NZ$14,223,000.00n/a-81.2x128.7x
Thu, 02 Sep 2021NZ$1.0bNZ$9.0m-NZ$14,223,000.00n/a-72.8x115.4x
Sat, 31 Jul 2021NZ$903.9mNZ$9.0m-NZ$14,223,000.00n/a-63.6x100.7x
Price to Earnings Ratio

-60.9x


Total Market Cap: NZ$866.1mTotal Earnings: -NZ$14,223,000.00Total Revenue: NZ$9.0mTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Biotech Industry Price to Earnings3Y Average -28.7x202220232024
Current Industry PE
    There is only one company in the New Zealander Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 42% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare industry?

NZ Market0.062%
Healthcare0.95%
Biotech8.89%
Biotech8.89%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PEB Pacific EdgeNZ$0.0988.9%
+NZ$6.5m
-78.5%PS3.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PEB

NZ$0.098

Pacific Edge

7D

8.9%

1Y

-78.5%